Back to search

Article

Is It the Time to Revolutionize the Heart Failure Management with Emerging Biomarkers and Innovative Targeted Treatments? From Re-Search Evidence to Clinic

2025-07-21

Abstract excerpt

Biomarkers are now considered valuable adjunctive tests for the diagnosis, prognosis and management of heart failure (HF). Natriuretic peptides have considerably improved the assessment and management of HF patients, but they have several limitations. Given the complex HF pathophysiology, no single biomarker can adequately address the diagnosis, prognosis and outcomes. Therefore, the use of multiple biomarkers can...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
94e12a7c-ce96-5d58-9d06-a945304678aa
DOI
10.20944/preprints202507.1640.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Is It the Time to Revolutionize the Heart Failure Management with Emerging Biomarkers and Innovative Targeted Treatments? From Re-Search Evidence to ClinicDOI 10.20944/preprints202507.1640.v1
Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized MedicineSemantic proximity
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSemantic proximity
Heart Failure in the Molecular Era: Redefining Our Understanding of Disease Mechanisms and PerspectivesSemantic proximity
Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology.Semantic proximity
Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction.Semantic proximity
Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.Semantic proximity
Omics phenotyping in heart failure: the next frontierSemantic proximity
404-Error “Disease Not Found”: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure ResearchSemantic proximity
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart StudySemantic proximity
The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.Semantic proximity
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy.Semantic proximity
Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAsSemantic proximity
Select a neighboring publication to make it the new centre.